1. Home
  2. AURA vs DDD Comparison

AURA vs DDD Comparison

Compare AURA & DDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AURA
  • DDD
  • Stock Information
  • Founded
  • AURA 2007
  • DDD 1986
  • Country
  • AURA United States
  • DDD United States
  • Employees
  • AURA N/A
  • DDD N/A
  • Industry
  • AURA Biotechnology: Pharmaceutical Preparations
  • DDD Computer peripheral equipment
  • Sector
  • AURA Health Care
  • DDD Technology
  • Exchange
  • AURA Nasdaq
  • DDD Nasdaq
  • Market Cap
  • AURA 396.8M
  • DDD 328.3M
  • IPO Year
  • AURA 2021
  • DDD N/A
  • Fundamental
  • Price
  • AURA $6.57
  • DDD $2.09
  • Analyst Decision
  • AURA Strong Buy
  • DDD Hold
  • Analyst Count
  • AURA 7
  • DDD 3
  • Target Price
  • AURA $22.29
  • DDD $3.50
  • AVG Volume (30 Days)
  • AURA 139.6K
  • DDD 5.2M
  • Earning Date
  • AURA 08-13-2025
  • DDD 08-11-2025
  • Dividend Yield
  • AURA N/A
  • DDD N/A
  • EPS Growth
  • AURA N/A
  • DDD N/A
  • EPS
  • AURA N/A
  • DDD N/A
  • Revenue
  • AURA N/A
  • DDD $413,342,000.00
  • Revenue This Year
  • AURA N/A
  • DDD N/A
  • Revenue Next Year
  • AURA N/A
  • DDD $2.43
  • P/E Ratio
  • AURA N/A
  • DDD N/A
  • Revenue Growth
  • AURA N/A
  • DDD N/A
  • 52 Week Low
  • AURA $4.35
  • DDD $1.32
  • 52 Week High
  • AURA $12.38
  • DDD $5.00
  • Technical
  • Relative Strength Index (RSI)
  • AURA 50.72
  • DDD 51.38
  • Support Level
  • AURA $6.20
  • DDD $1.99
  • Resistance Level
  • AURA $6.80
  • DDD $2.70
  • Average True Range (ATR)
  • AURA 0.29
  • DDD 0.16
  • MACD
  • AURA -0.00
  • DDD -0.03
  • Stochastic Oscillator
  • AURA 67.14
  • DDD 24.07

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

About DDD 3D Systems Corporation

3D Systems Corp provides comprehensive 3D printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, and services, including maintenance, advanced manufacturing and applications engineering. The company's segments include Healthcare Solutions and Industrial Solutions. It generates maximum revenue from the Industrial segment. It conducts business through various offices and facilities located throughout the Americas, EMEA, and APAC; generating a vast majority of revenues from the Americas.

Share on Social Networks: